Icône BioRender

Electroporation chamber (Xenon, with liquid)

Electroporation chamber (Xenon, with liquid) - Editable icon of a Xenon electroporation chamber filled with liquid
[{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc9512e/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc9512e/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc9512f/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc9512f/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc95130/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc95130/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc95131/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc95131/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc95132/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc95132/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc95133/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc95133/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc95134/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc95134/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc95135/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc95135/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc95136/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc95136/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc95137/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc95137/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc95138/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc95138/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc95139/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc95139/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc9513a/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc9513a/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc9513b/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc9513b/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc9513c/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc9513c/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc9513d/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc9513d/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc9513e/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc9513e/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc9513f/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc9513f/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc95140/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc95140/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc95141/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc95141/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc95142/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc95142/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc95143/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc95143/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc95144/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc95144/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc95145/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc95145/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc95146/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc95146/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc95147/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc95147/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc95148/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc95148/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc95149/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc95149/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc9514a/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc9514a/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc9514b/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc9514b/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc9514c/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc9514c/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc9514d/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc9514d/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc9514e/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc9514e/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc9514f/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc9514f/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc95150/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc95150/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc95151/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc95151/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc95152/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc95152/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc95153/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc95153/67c1e2b76f3e89601b3e5832.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67c1e2eb9478ccc12cc95154/67c1e2b76f3e89601b3e5832.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67c1e2eb9478ccc12cc95154/67c1e2b76f3e89601b3e5832.png"}]
Utiliser cette icône – Gratuit
Aucune carte de crédit requise pour l'inscription.

Cette icône est entièrement modifiable dans BioRender

  • Ajoutez du texte, des formes et d'autres icônes
  • Recherchez parmi plus de 50 000 icônes scientifiquement exactes
  • Changez les couleurs et réorganisez chaque icône, ligne et étiquette
  • Exportez ou partagez pour tout type d'utilisation
Scientist Avatars

Rejoignez plus de 4 millions de scientifiques qui créent déjà des figures prêtes à être publiées

Passez des icônes à la figure terminée – en quelques minutes

  • Rechercher à partir de plus de 50 000 icônes scientifiquement exactes et évaluées par des pairs
  • Personnalisez avec des étiquettes, des formes et des icônes supplémentaires – tout est entièrement modifiable
  • Exporter ou partagez vos figures avec vos collaborateurs
    ‍
page dashboard

Ce n'est pas tout à fait l'icône qu'il vous faut ? Découvrez-en plus.

Recherchez parmi plus de 50 000 icônes dans plus de 30 domaines des sciences de la vie.

search icon
arrow-right
electroporation chamber,CTS Xenon,Gibco,electroporation system,consumable,single shot,cell preparation,cell therapy,stem cell manufacturing,gene editing,cell therapy,genome engineering,transfection,cell electroporation,high-efficiency delivery,mrna delivery,dna delivery,crispr delivery,cellular reprogramming,primary cell modification,stem cell engineering,t-cell modification,immunotherapy,cancer research,synthetic biology,biopharmaceuticals,electroporation chamber,single-use chamber,sterile processing,closed-system design,uniform electric field,pulse generator compatibility,high-throughput processing,scalable cell modification,controlled pulse application,real-time monitoring,sterile connectors,biomanufacturing,cell and gene therapy,vector-free transfection,ex vivo cell engineering,single-shot electroporation,modular electroporation system,programmable pulse settings,high-yield transfection,cell suspension processing,gmp-compliant,flow-through electroporation,buffer solutions,cell culture media,customizable electroporation protocols,low-volume processing,scalable gene delivery,biotech,pharmaceutical research,clinical trial development,personalized medicine,nanoparticle delivery,exosome loading,neuroscience,stem cell research,immune cell engineering,regenerative medicine,tissue engineering,liquid,media,front,front view,anterior,frontal,anterior view,,Thermo Fisher,CTS Xenon,Gibco
Voir plus

Essayez un synonyme, ou inscrivez-vous pour demander une icône depuis l'application.

Types d'images

Electroporation chamber (Xenon, with liquid) icon JPEG

Electroporation chamber (Xenon, with liquid) icon PNG

Electroporation chamber (Xenon, with liquid) icon SVG

Electroporation chamber (Xenon, with liquid) icon GIF

FAQ sur les icônes BioRender

How are scientists using the Electroporation chamber (Xenon, with liquid) icon in their work?

BioRender users often use the Electroporation chamber (Xenon, with liquid) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Lab and Objects.

Puis-je utiliser cette icône dans une figure ou une illustration scientifique BioRender ?

Yes, the Electroporation chamber (Xenon, with liquid) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Electroporation chamber (Xenon, with liquid) icon customizable in BioRender?

Most icons in BioRender, including the Electroporation chamber (Xenon, with liquid) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Electroporation chamber (Xenon, with liquid) icon for publication or presentations?

Yes, figures containing the Electroporation chamber (Xenon, with liquid) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Electroporation chamber (Xenon, with liquid) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Electroporation chamber (Xenon, with liquid) icon — especially those focused on Lab and Objects. You can search BioRender’s template library or add this icon manually to any canvas.

Qu'est-ce que BioRender ?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Electroporation chamber (Xenon, with liquid) icon along with our library of more than 30,000 life science icons.

Utiliser cette icône dans BioRender

Créez dès aujourd'hui des illustrations scientifiques professionnelles
antibody elements3D Phospholipid illustration

Vous recherchez du contenu scientifique ?

Parcourez plus de 50 000 icônes et modèles validés par des pairs, faciles à utiliser et gratuits.

Trouvez le vôtre dès maintenant
x icon